Kenneth Keller

Kenneth Keller

Direttore/Membro del Consiglio presso AMBIT BIOSCIENCES CORP
63 anni
Health Technology
Consumer Services

Profilo

Kenneth Joseph Keller is currently Chairman, President & Chief Executive Officer at Daiichi Sankyo, Inc. since 2014.
Mr. Keller is also Director at Ambit Biosciences Corp.
since 2014.
Mr. Keller serves as Director & Head-Oncology Business Unit at Daiichi Sankyo Co., Ltd. starting in 2021.
Formerly, Mr. Keller was President & Chief Executive Officer at American Regent, Inc. from 2016 to 2021.
Mr. Keller was Chief Operating Officer & Executive Vice President at Spectrum Pharmaceuticals, Inc. from 2012 to 2014.
Mr. Keller earned an MBA from Loyola Marymount University and completed undergraduate studies at St. John's University.

Posizioni attive di Kenneth Keller

SocietàPosizioneInizio
AMBIT BIOSCIENCES CORP Direttore/Membro del Consiglio 10/11/2014
DAIICHI SANKYO COMPANY, LIMITED Direttore/Membro del Consiglio 01/06/2025
Amministratore Delegato 01/03/2014

Precedenti posizioni note di Kenneth Keller

SocietàPosizioneFine
Amministratore Delegato 01/04/2021
SPECTRUM PHARMACEUTICALS, INC. Direttore operativo 17/04/2014
Vedi nel dettaglio l'esperienza di Kenneth Keller

Formazione di Kenneth Keller

Esperienze
Posizioni ricoperte

Attive

Inattive

Società nel listino

Aziende private

Relazioni

33

Relazioni di 1° grado

7

Aziende connesse in 1º grado

Uomo

Donna

Amministratori

Dirigenti

Società collegate

Aziende private7

Health Technology

Health Technology

Consumer Services

Consumer Services

Health Technology

Health Technology

Health Technology

  1. Mercati
  2. Insiders
  3. Kenneth Keller